Please tell us what you thought about today’s presentation by taking the survey below:
The use of digital tools for the treatment of patients with mental illness is a dynamic and rapidly growing area of interest. In this webinar, Dr. Michael E. Thase, MD and Dr. Craig Chepke, MD will discuss unmet treatment needs in serious mental illness and substance use disorder. They will also explore how digital technologies may help to address these needs by reviewing tools currently used to help manage depression, bipolar disorder, schizophrenia, and substance use. Additionally, the speakers will discuss what the future may hold for digital technologies in the management of patients with mental health disorders.
Moderator:
Mark Tacelosky, PharmD
Clinical & Scientific Liaison
Michael Thase, MD
Professor of Psychiatry, Perelman School of Medicine; Director of the Mood & Anxiety Disorders Section; Researcher, Corporal Michael J. Crescenz Veterans Affairs Medical Center at the University of Pennsylvania
Craig Chepke, MD, FAPA
Board-Certified Psychiatrist, Fellow of the American Psychiatric Association, Private practice at Excel Psychiatric Associates in Huntersville, NC, Adjunct Associate Professor of Psychiatry for Atrium Health and University of North Carolina School of Medicine
Mark Tacelosky, PharmD
Senior Medical Science Liaison
Dr. Michael E. Thase and Dr. Craig Chepke are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. Mark Tacelosky, PharmD, is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Notifications
